Susquehanna Fundamental Investments’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-22,321
| Closed | -$34.8K | – | 830 |
|
|
2023
Q1 | $34.8K | Hold |
22,321
| – | – | ﹤0.01% | 929 |
|
|
2022
Q4 | $14.2K | Sell |
22,321
-4,613
| -17% | -$2.94K | ﹤0.01% | 1163 |
|
|
2022
Q3 | $36K | Buy |
+26,934
| New | +$36K | ﹤0.01% | 1383 |
|
|
2021
Q4 | – | Sell |
-14,059
| Closed | -$1.29M | – | 1710 |
|
|
2021
Q3 | $1.29M | Buy |
14,059
+6,580
| +88% | +$603K | 0.02% | 760 |
|
|
2021
Q2 | $396K | Buy |
+7,479
| New | +$396K | 0.01% | 1258 |
|
|
2020
Q4 | – | Sell |
-17,177
| Closed | -$859K | – | 1583 |
|
|
2020
Q3 | $859K | Buy |
17,177
+7,700
| +81% | +$385K | 0.03% | 691 |
|
|
2020
Q2 | $439K | Buy |
+9,477
| New | +$439K | 0.02% | 647 |
|